Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 1997

View Archived Issues

Creative BioMolecules: Q1 1997 highlights

CytoTherapeutics: Q1 1997 highlights

Hybridon: Q1 1997 highlights

Flamel Technologies: Report to investors at Alex, Brown Health Care Conference

Cypros: Report to investors at Van Kasper & Co. Growth Stock Conference

Selective M3 antagonists from Banyu

Kyoto describes ACAT/lipid peroxidation inhibitors

Nissan Chem. reveals antiplatelet agents

Hayashibara discloses potent, broad-spectrum antitumor agents

Ono reports AGE inhibitors and antioxidants

Heat shock protein fragments for RA from Peptide Therapeutic

Taisho prepares inhibitors of the production of IL-1beta/IL-6

Activated Cell Therapy's immunotherapy for prostate cancer enters clinic

Alphagan introduced in the U.K.

U.K. introduction for Nasonex

Integrin recognition surface identified

Loxiglumide efficacy in GERD reported

Fujisawa's new agent for hepatic ischemia-reperfusion injury

Bristol-Myers Squibb strengthens R&D in the Czech Republic

Gen-Probe and bioMerieux sign nucleic acid probe diagnostic agreement

Lamivudine clinical results in HBV

Gastric roles of COX-1 and COX-2 debated at DDW

Pasteur Merieux Connaught launches combination vaccine with acellular component

News on gastric ulcer drugs reported at Digestive Disease Week

Vital to develop anticancer drug

NIH sponsors ProScript's research on novel malaria treatment

Oxigene signs agreement for combretastatin development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...